Industry

OK-101 to treat ocular diseases, including Dry Eye Disease (DED), uveitis, allergic conjunctivitis, and ocular pain. Successful pre-IND meeting with FDA in Q1 2022 and novel speed to market potential. IND filing on OK-101 to treat DED planned for Q4 2022, with first human trial designed as Phase 2 trial planned to begin in Q1 … [Read more…]

LEWISVILLE, Texas–(BUSINESS WIRE)–CareView Communications, Inc. (“CareView” or the “Company”) (OTCQB: CRVW), an information technology provider to the healthcare industry, today announced its latest updates to its CareView Patient Safety System®, Version 5.6, which includes system integration with Vocera and Hillrom, paving the way for a new paradigm in clinical workflow management. With these integrations, safety … [Read more…]

New funding round led by Nina Capital enables Healee to empower unique digital health models and accelerate telehealth adoption TAMPA, Fla.–(BUSINESS WIRE)–#custom—Healee, providing highly configurable digital health technology, announced today that it has raised $2M in a seed round led by Nina Capital, with the participation of Calm/Storm Ventures, KAYA VC and existing investor Eleven … [Read more…]

Cotiviti and health plan executives will discuss how to intelligently drive member interventions and achieve premium accuracy SALT LAKE CITY–(BUSINESS WIRE)–Cotiviti, a leader in data-driven healthcare solutions, will present on optimizing health plan risk adjustment programs at the RISE West conference in Los Angeles, taking place August 31–September 2, 2022. Cotiviti’s RaeAnn Grossman, executive vice … [Read more…]

HENDERSON, Nev.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of James Messina as a non-Executive Director to its board. Mr. Messina is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by … [Read more…]

– Clinical milestone marks initiation of first ever novel psilocybin analog to enter clinical development – TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, is pleased to announce that the first two participants have been dosed in its Phase 1/2a trial evaluating CYB003 for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global PCR And Realtime PCR testing Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global PCR and realtime PCR testing market is expected to grow from $18.5 billion in 2021 to $19.64 billion in 2022 at a compound annual growth rate (CAGR) of 6.2%. The market is expected to grow … [Read more…]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), today announced that it has been selected to conduct an oral presentation covering the novel THIO platform at the XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids, which will be taking place in Stockholm, Sweden on … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Molecular Diagnostics Devices And Equipment Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global molecular diagnostics devices and equipment market is expected to grow from $24.19 billion in 2021 to $27.91 billion in 2022 at a compound annual growth rate (CAGR) of 15.3%. The market is expected to grow … [Read more…]

DETROIT–(BUSINESS WIRE)–Together Women’s Health (“TWH” or “the Company”) is pleased to announce it has entered the Illinois market with the affiliation of both Northwestern Specialists for Women (“NSW”) and North Shore Associates in Gynecology and Obstetrics (“NSAGO”), adding 22 providers and three locations to the TWH network. Together Women’s Health is a women’s health focused … [Read more…]